(Q40114261)

17 September 2017

title

Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location (English)

1 reference

colorectal adenocarcinoma

17 September 2017

1 reference

1 reference

Talia Golan

1

1 reference

17 September 2017

Damien Urban

series ordinal

2

1 reference

17 September 2017

Raanan Berger

series ordinal

3

1 reference

17 September 2017

Yaacov Richard Lawrence

series ordinal

4

1 reference

17 September 2017

language of work or name

English

0 references

publication date

29 May 2013

1 reference

17 September 2017

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

17 September 2017

volume

119

1 reference

17 September 2017

issue

16

1 reference

17 September 2017

page(s)

3084-3091

1 reference

17 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Management and survival of colorectal cancer in the elderly in population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Effects of socioeconomic status and treatment disparities in colorectal cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

The illness trajectory of elderly cancer patients across cultures: SIOG position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

Hepatic resection: the last surgical frontier for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

7 January 2021

inferred from DOI database lookup

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

7 January 2021

inferred from DOI database lookup

Improvement in colorectal cancer survival: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28143

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CNCR.28143

1 reference

17 September 2017

1 reference